International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 536-545

  Paloma Vizcaino, A ^a   Moreno, Victor ^b   Xavier Bosch, F ^b   Muñoz, Nubia ^a   Barros Dios, Xoán M ^c   Maxwell Parkin, D ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; COHORT ANALYSIS; DENMARK; ETHNIC GROUP; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; NEW ZEALAND; PREVALENCE; PRIORITY JOURNAL; SINGAPORE; SLOVAKIA; SLOVENIA; SWEDEN; UNITED KINGDOM; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; REGISTRIES; UTERINE CERVICAL NEOPLASMS;

EID: 2642629704     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U     Document Type: Article

References (51)

1. ANTON-CULVER, H.A., BLOSS, J.D., BRINGMAN, D., LEE-FELDSTEIN, A., DISAIA, P. and MANETTA, A., Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Amer. J. Obstet. Gynecol., 166, 1507-1514 (1992).
2. ARRAIZ, G.A., WIGLE, D.T. and MAO, Y., Is cervical cancer in increased among young women in Canada? Canad. J. publ. Health, 81, 396-397 (1990).
3. BERAL, V., HERMON, C., MUÑOZ, N. and DEVESA, S., Cervical cancer. Cancer Surv., 19/20, 265-284 (1994).
4. BJERSING, L., ROGO, K., EVANDER, M., GERDES, U., STENDAHL, U. and WADELL, G., HPV18 and cervical adenocarcinoma. Anticancer Res., 11, 123-127 (1991).
5. BOSCH, F.X., MANOS, M., MUÑOZ N., SHERMAN, M., JANSEN, A., PETO, J., SCHIFFMAN, M., MORENO, V., SHAH, K.V. and the IBSCC STUDY GROUP, Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. nat. Cancer Inst., 87, 796-802 (1995).
6. BOSCH, F.X. AND 15 OTHERS, Risk factors for cervical cancer in Colombia and Spain. Int. J. Cancer, 52, 750-758 (1992).
7. BRESLOW, N.E., Extra-Poisson variation in log-linear models. Appl. Statist., 33, 38-44 (1984).
8. BRINTON, L.A., HUGGINS, G.R., LEHMAN, H.F., MALLIN, K., SAVITZ, D.A., TRAPIDO, E., ROSENTHAL, J. and HOOVER, R., Long-term use of oral contraceptives and risk of invasive cervical cancer. Int. J. Cancer, 38, 339-344 (1986).
9. BRINTON, L.A., REEVES, W.C., BRENES, M.M., HERRERO, R., DE BRITTON, R.C., GAITAN, E., TENORIO, F., GARCIA, M. and RAWLS, W.E., Oral contraceptive use and risk of invasive cervical cancer. Int. J. Epidemiol., 19, 4-11 (1990).
10. BRINTON, L.A., TASHIMA, K.T., LEHMAN, H.F., LEVINE, R.S., MALLIN, K., SAVITZ, D.A., STOLLEY, P.D. and FRAUMENI, J.F., Epidemiology of cervical cancer by cell type. Cancer Res., 47, 1706-1711 (1987).
11. BUNTINX, F. and BROUWERS, M., Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomised and quasi-randomised studies. Brit. med. J., 313, 1285-1276 (1996).
12. CHILVERS, C., MANT, D. and PIKE, M.C., Cervical cancer adenocarcinoma and oral contraceptives. Brit. med. J. clin. Res., 295, 1446-1447 (1987).
13. CLAYTON, D. and SCHIFFLERS, E., Models for temporal variation in cancer rates. II: Age-period-cohort models. Statist. Med., 6, 469-481 (1987).
14. COLEMAN, M.P., ESTÈVE, J., DAMIECKI, P., ARSLAN, A. and RENARD, H., Trends in cancer incidence and mortality. IARC Scientific Publication 121, IARC, Lyon (1993).
15. Cox, B. and SKEGG, D.C.G., Trends in cervical cancer in New Zealand. New Zeal. med. J., 99, 795-798 (1986).
16. DAVIS, J.R. and MOON, L.B., Increased incidence of adenocarcinoma of the uterine cervix. Obstet. Gynecol., 45, 79-83 (1975).
17. DEVESA, S.S., YOUNG, J.L., BRINTON, L.A. and FRAUMENI, J.F. JR., Recent trends in cervix uteri. Cancer, 64, 2184-2190 (1989).
18. EIDE, T.J., Cancer of the uterine cervix in Norway by histological type 1970-84. J. nat. Cancer Inst., 79, 199-205 (1987).
19. ELUF-NETO, J., BOOTH, M., MUÑOZ, N., BOSCH, F.X., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Human papillomavirus and invasive cervical cancer in Brazil. Brit. J. Cancer, 69, 114-119 (1994).
20. ESTÈVE, J., International study of time trends. Some methodological consideration. Ann. N. Y. Acad. Sci., 609, 77-84 (1990).
21. ESTÈVE, J., BENHAMOU, E. and RAYMOND, L., Descriptive epidemiology. Statistical methods in cancer research. Vol. IV. IARC Scientific Publication 128. IARC, Lyon (1994).
22. Fu, Y.S., BEREK, J.S. and HILBORNE, L.H., Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl. Pathol., 5, 47-56 (1987).
23. GOVERNMENT STATISTICAL SERVICE, CERVICAL SCREENING PROGRAMME, ENGLAND: 1995-95. DEPARTMENT OF HEALTH, 1996. (STATISTICAL BULLETIN 1996/3).
24. HERBERT, A., JOHNSON, J. and PATNICK, J., Achievable standards, benchmarks for reporting, criteria for evaluating cervical cytopathology. Cytopathology, 6, 301-303 (1995).
25. HOLFORD, T.R., The estimates of age, period and cohort effects for vital rates. Biometrics, 39, 311-324 (1983).
26. HOLMAN, D. and ARMSTRONG, B.K., Cervical cancer mortality trends in Australia: an update. Med. J. Austral., 146, 410-412 (1987).
27. HOPKINS, M.P. and MORLEY, G.W., A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstetr. Gynecol., 77, 912-917 (1991).
28. IARC, The epidemiology of human papillomavirus and cervical cancer. IARC Scientific Publication 119. IARC, Lyon (1992).
29. IARC, Monographs on the evaluation of the carcinogenic risk to humans, Vol. 64. Human papillomaviruses. IARC, Lyon (1995).
30. KJAER, S.K. and BRINTON, L.A., Adenocarcinoma of the uterine cervix: the epidemiology of an increasing problem. Epidemiol. Rev., 15, 486-495 (1993).
31. KORHONEN, M.O., Epidemiological differences between adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol. Oncol., 10, 312-317 (1980).
32. LAARA, E., DAY, N.E. and HAKAMA, M., Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programs. Lancet, i, 1247-1249 (1987).
33. LEMINEN, A., PAAVONEN, J., FORSS, M., WAHLTROM, T. and VESTERINEN, E., Adenocarcinoma of the uterine cervix. Cancer, 65, 53-59 (1990).
34. MITCHELL, H., MEDLEY, G., GORDON, I. and GILES, G., Cervical cytology reported as negative risk of adenocarcinomas of the cervix: no strong evidence of benefit. Brit. J. Cancer, 71, 894-897 (1995).
35. MITCHELL, H. and MEDLEY, G., Longitudinal study of women with negative cervical smears according to endocervical status. Lancet, 337, 265-267 (1991).
36. MUIR, C., WATERHOUSE, J., MACK, T., POWELL, J. and WHELAN, S. (EDS.), Cancer incidence in five continents. Vol. V. IARC Scientific Publication 88. IARC, Lyon (1987).
37. MUÑOZ, N., BOSCH, F.X., NGELANGEL, C., CHICHAREON, S., CHAOUKI, N., HERRERO, R., MEIJER, D.J.L.M. and WALBOOMERS, J.M.M., Risk of invasive cervical cancer by types of HPV: a multi-centre case-control study. 15th International Papillomavirus Workshop. Brisbane, p. 69 (1996).
38. NIEMINEN, P.M., KALLIO, M. and HAKAMA, M., The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstetr. Gynecol., 85, 1017-1020 (1995).
39. PARAZZINI, F., LA VECCHIA, C., NEGRI, E., FASOLI, M. and CECCHETTI, G., Risk factors for adenocarcinoma of the cervix: a case control study. Brit. J. Cancer, 57, 201-204 (1988).
40. PARKIN, D.M., MUIR, C.S., WHELAN, S.L., GAO, Y.T., FERLAY, J. and POWELL, L. (EDS.), Cancer incidence in five continents. Vol. VI. IARC Scientific Publication 120. IARC, Lyon (1992).
41. PETERS, R.K., CHAO, A., MACK, T.M., THOMAS, D., BERNSTEIN, L. and HENDERSON, B.E., Increased frequency of adenocarcinomas of the uterine cervix in young women in Los Angeles County. J. nat. Cancer Inst., 76, 423-428 (1986).
42. SASIENI, P.D., CUZICK, J. and LYNCH-FARMERY, E., Estimating the efficiency of screening by auditing smear histories of women with and without cervical cancer. Brit. J. Cancer, 73, 1001-1005 (1996).
43. SCHWARTZ, P.E., HADJIMICHAEL, O., LOWELL, D.M., MERINO, M.J. and JANERICH, D., Rapidly progressive cervical cancer: the Connecticut experience. Amer. J. Obstetr. Gynecol., Suppl. 2, 1105-1109 (1996).
44. SCHWARTZ, S.M. and WEISS, N.S., Increased incidence of adenocarcinoma of the cervix in young women in the United States. Amer. J. Epidemiol., 124, 1045-1047 (1986).
45. SILCOCKS, P.B.S., THORNTON, J. and MURPHY, M., Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Brit. J. Cancer, 55, 321-325 (1987).
46. URSIN, G., PETERS, R.K., HENDERSON, B.E., D'ABLAING III, G., MONROE, K.R. and PIKE, M.C., Oral contraceptive use and adenocarcinoma of the cervix. Lancet, 344, 1390-1394 (1994).
47. URSIN, G., PIKE, M.C., PRESTON-MARTIN, S., D'ABLAING III, G. and PETERS, R.K., Sexual, reproductive, and other risk factors for adenocarcinomas of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control, 7, 391-401 (1996).
48. VESTERINEN, E., FORSS, M. and NIEMINEN, U., Increase of cervical cancer: a report of 520 cases of cervical carcinoma including 112 tumours with glandular elements. Gynecol. Oncol., 33, 49-53 (1989).
49. WATERHOUSE, J., MUIR, C., SHANMUGARATNAM, K. and POWELL, J. (EDS.), Cancer incidence in five continents. Vol. IV. IARC, Lyon (1982).
50. WEBB, M.J. and SHEEHAN, T.M., Invasive carcinoma of the cervix in young women. Austr. New Zeal. J. Obstetr. Gynaecol., 29, 47-51 (1989).
51. ZHENG, T., HOLFORD, T., MA, Z., CHEN, Y., LIU, W., WARD, B. and BOYLE, P., The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int. J. Epidemiol., 25, 252-257 (1996).